News tagged with malignant cells
Related topics: cells , breast cancer , cancer , cancer cells , tumor cells
Rat study shows chrysotile asbestos is strong carcinogen
(HealthDay) -- Chrysotile, a commercially used type of asbestos, induces malignant mesothelioma (MM) in the rat peritoneal cavity, with pathogenesis strongly linked to iron overload, according to a study ...
Medical research
Aug 14, 2012 |
2 / 5 (2) |
0
Bortezomib beneficial in graft-versus-host disease prophylaxis
(HealthDay) -- Patients with hematologic malignancies undergoing an HLA-mismatched unrelated donor (MMUD) reduced-intensity conditioning (RIC) hematopoietic stem cell transplantation (HSCT) may benefit from ...
Cancer
Aug 08, 2012 |
not rated yet |
0
Study suggests new treatment target for glioblastoma multiforme
A study by UT Southwestern Medical Center researchers published online today in Nature reveals new insight into why the most common, deadly kind of brain tumor in adults recurs and identifies a potential target ...
Cancer
Aug 01, 2012 |
5 / 5 (1) |
0
|
Immune responses can be generated locally within human melanoma skin metastases
In many types of cancer, activated immune cells infiltrate the tumor and influence clinical outcome. It is not always clear where these cells are activated, but results reported in Cancer Research, a journal of the Americ ...
Cancer
Jul 31, 2012 |
not rated yet |
0
|
People with darker skin still at risk for melanoma
(HealthDay) -- Skin cancer is more common among white people, but people with darker skin are also at risk, a dermatology expert cautions.
Cancer
Jul 26, 2012 |
5 / 5 (2) |
0
Researchers find potential key to new treatment for mantle cell lymphoma
Researchers at Moffitt Cancer Center and colleagues have demonstrated that the inhibition of signal transducer and activator of transcription 3 (STAT3) in mouse models of mantle cell lymphoma (MCL), an aggressive and incurable ...
Cancer
Jul 18, 2012 |
not rated yet |
0
|
Scientists gain new insights into Taspase1 function
Scientists at the University Medical Center of Johannes Gutenberg University Mainz in Germany identified a novel strategy to target the oncologically relevant protein-cleaving enzyme Taspase1. Taspase1 levels are not only ...
Cancer
Jul 10, 2012 |
not rated yet |
0
Identification of a novel target for glioblastoma treatment
(Medical Xpress) -- A recent study from scientists at the Friedrich Miescher Institute for Biomedical Research has identified a novel target for the treatment of malignant brain tumors. The scientists found ...
Cancer
Jun 18, 2012 |
5 / 5 (1) |
0
|
The Medical Minute: What is myelodysplastic syndrome?
Television journalist and host of "Good Morning America" Robin Roberts announced this week that she has myelodysplastic syndrome, or MDS, an uncommon blood and bone marrow disorder.
Cancer
Jun 15, 2012 |
not rated yet |
1
New trial drug a 'Trojan Horse' attacking pancreatic cancer
An investigational drug that acts like a Trojan Horse to deliver cancer killing agents for pancreatic cancer is being studied at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare ...
Cancer
Jun 14, 2012 |
not rated yet |
0
Studies show that pancreatic cancer can run but not always hide from the immune system
A pair of recent studies describes how pancreatic cancer cells produce a protein that attracts the body's immune cells and tricks them into helping cancer cells grow. The research, published by Cell Press in the June 12th ...
Cancer
Jun 11, 2012 |
not rated yet |
0
|
New immune therapy shows promise in kidney cancer
An antibody that helps a person's own immune system battle cancer cells shows increasing promise in reducing tumors in patients with advanced kidney cancer, according to researchers at Beth Israel Deaconess Medical Center.
Cancer
Jun 04, 2012 |
not rated yet |
0
Scientists see potential in novel leukemia treatment
Scientists at Virginia Commonwealth University Massey Cancer Center may be one step closer to developing a new therapy for acute myeloid leukemia (AML) after discovering that the targeted agents obatoclax and sorafenib kill ...
Cancer
May 22, 2012 |
5 / 5 (3) |
0
Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy
Pushed to the brink of survival, the hyper-driven cells of a cancerous tumor tap into an ancient system that has helped organisms cope with internal stresses and environmental challenges since life began. As an integral part ...
Cancer
May 22, 2012 |
not rated yet |
0
Exhaustion renders immune cells less effective in cancer treatment
Rather than stimulating immune cells to more effectively battle cancerous tumors, treatment with the protein interleukin-12 (IL-12) has the opposite effect, driving these intracellular fighters to exhaustion, a Mayo Clinic ...
Immunology
May 09, 2012 |
not rated yet |
0
